Herpesvirus antigens as markers for cervical cancer

A total of 393 patients representing cervical atypias, cancers, and nonneoplastic disease have been studied. Cellular specimens have been stained with antisera raised against total herpes type 2 virus (HSV-2) and subfractions labeled crude AG-e, pure AG-e, ICP 12, and ICP 14. Reproducibility, statis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecologic oncology 1981-10, Vol.12 (2), p.S232-S258
Hauptverfasser: Gupta, Prabodh K., Aurelian, Laure, Frost, John K., Carpenter, Jean M., Klacsmann, Karen T., Rosenshein, Neil B., Tyrer, Harry W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S258
container_issue 2
container_start_page S232
container_title Gynecologic oncology
container_volume 12
creator Gupta, Prabodh K.
Aurelian, Laure
Frost, John K.
Carpenter, Jean M.
Klacsmann, Karen T.
Rosenshein, Neil B.
Tyrer, Harry W.
description A total of 393 patients representing cervical atypias, cancers, and nonneoplastic disease have been studied. Cellular specimens have been stained with antisera raised against total herpes type 2 virus (HSV-2) and subfractions labeled crude AG-e, pure AG-e, ICP 12, and ICP 14. Reproducibility, statistical significance, false positive and false negative results, specificity, and sensitivity of the various antisera have been investigated. Correlation of immunocytostaining with Papanicolaou staining has been made. Usefulness of these markers in the detection and diagnosis of premalignant and malignant cervical epithelial changes for mass screening has been discussed. Using crude AG-e, pure AG-e, HSV-2, and HSV-1 antisera in a number of blind studies, no significant differences were found in the reproducibility of results. Observations indicated that a minimum of 30 cells must be analyzed to make data amenable to statistical analysis. Exfoliated cells from 62, 75, 77, and 94% of patients respectively diagnosed as mild, moderate, and marked atypia, and cancer were studied with antisera against total HSV-2. Similar results were observed with antisera against pure AG-e. No patient reacted with anti-AG-e or anti-HSV-1 antiserum in the absence of reactivity to antisera against total HSV-2 antigens. Studies using anti-ICP 12 and -ICP 14 antigens established the wide and specific staining character of anti-HSV-2 antisera. Morphologic preservation of cells by Papanicolaou staining after the FA procedures was considered satisfactory for diagnostic purposes. Our studies indicated the potential usefulness of anti-HSV-2 and anti-AG-e antisera in mass cervical cancer screening programs and cytology automation.
doi_str_mv 10.1016/0090-8258(81)90077-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73756300</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0090825881900779</els_id><sourcerecordid>73756300</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-22be2b5df88215bef028a488466e116469591d1ffe89f12649a373087c28d3553</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotVb_gcKsRBejeUxeG0GKWqHgRtchk7mR6HSmJjMF_72pLS5d3QP3nHs5H0LnBN8QTMQtxhqXinJ1pci1xljKUh-gKcGal0JxfYimf5ZjdJLSB8aYYUInaCKoZFSwKWILiGtImxDHVNhuCO_QZZGKlY2fEFPh-1g4iJvgbFs422V9io68bROc7ecMvT0-vM4X5fLl6Xl-vywd43IoKa2B1rzxSlHCa_CYKlspVQkBhIhKaK5JQ7wHpT2hotKWSYaVdFQ1jHM2Q5e7u-vYf42QBrMKyUHb2g76MRnJJBcsd5qhamd0sU8pgjfrGHKBb0Ow2bIyWxBmC8IoYn5ZGZ1jF_v7Y72C5i-0h5P3d7s95JKbANEkFyATaEIEN5imD_8_-AG6QHaF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73756300</pqid></control><display><type>article</type><title>Herpesvirus antigens as markers for cervical cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gupta, Prabodh K. ; Aurelian, Laure ; Frost, John K. ; Carpenter, Jean M. ; Klacsmann, Karen T. ; Rosenshein, Neil B. ; Tyrer, Harry W.</creator><creatorcontrib>Gupta, Prabodh K. ; Aurelian, Laure ; Frost, John K. ; Carpenter, Jean M. ; Klacsmann, Karen T. ; Rosenshein, Neil B. ; Tyrer, Harry W.</creatorcontrib><description>A total of 393 patients representing cervical atypias, cancers, and nonneoplastic disease have been studied. Cellular specimens have been stained with antisera raised against total herpes type 2 virus (HSV-2) and subfractions labeled crude AG-e, pure AG-e, ICP 12, and ICP 14. Reproducibility, statistical significance, false positive and false negative results, specificity, and sensitivity of the various antisera have been investigated. Correlation of immunocytostaining with Papanicolaou staining has been made. Usefulness of these markers in the detection and diagnosis of premalignant and malignant cervical epithelial changes for mass screening has been discussed. Using crude AG-e, pure AG-e, HSV-2, and HSV-1 antisera in a number of blind studies, no significant differences were found in the reproducibility of results. Observations indicated that a minimum of 30 cells must be analyzed to make data amenable to statistical analysis. Exfoliated cells from 62, 75, 77, and 94% of patients respectively diagnosed as mild, moderate, and marked atypia, and cancer were studied with antisera against total HSV-2. Similar results were observed with antisera against pure AG-e. No patient reacted with anti-AG-e or anti-HSV-1 antiserum in the absence of reactivity to antisera against total HSV-2 antigens. Studies using anti-ICP 12 and -ICP 14 antigens established the wide and specific staining character of anti-HSV-2 antisera. Morphologic preservation of cells by Papanicolaou staining after the FA procedures was considered satisfactory for diagnostic purposes. Our studies indicated the potential usefulness of anti-HSV-2 and anti-AG-e antisera in mass cervical cancer screening programs and cytology automation.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/0090-8258(81)90077-9</identifier><identifier>PMID: 6273263</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antigens, Viral - analysis ; Carcinoma, Squamous Cell - immunology ; Cells, Cultured ; Female ; Fluorescent Antibody Technique ; Herpes Genitalis - immunology ; Humans ; Immune Sera ; Male ; Mass Screening ; Simplexvirus - immunology ; Specimen Handling ; Uterine Cervical Dysplasia - immunology ; Uterine Cervical Neoplasms - immunology ; Vaginal Smears</subject><ispartof>Gynecologic oncology, 1981-10, Vol.12 (2), p.S232-S258</ispartof><rights>1981</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-22be2b5df88215bef028a488466e116469591d1ffe89f12649a373087c28d3553</citedby><cites>FETCH-LOGICAL-c357t-22be2b5df88215bef028a488466e116469591d1ffe89f12649a373087c28d3553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0090825881900779$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6273263$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, Prabodh K.</creatorcontrib><creatorcontrib>Aurelian, Laure</creatorcontrib><creatorcontrib>Frost, John K.</creatorcontrib><creatorcontrib>Carpenter, Jean M.</creatorcontrib><creatorcontrib>Klacsmann, Karen T.</creatorcontrib><creatorcontrib>Rosenshein, Neil B.</creatorcontrib><creatorcontrib>Tyrer, Harry W.</creatorcontrib><title>Herpesvirus antigens as markers for cervical cancer</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>A total of 393 patients representing cervical atypias, cancers, and nonneoplastic disease have been studied. Cellular specimens have been stained with antisera raised against total herpes type 2 virus (HSV-2) and subfractions labeled crude AG-e, pure AG-e, ICP 12, and ICP 14. Reproducibility, statistical significance, false positive and false negative results, specificity, and sensitivity of the various antisera have been investigated. Correlation of immunocytostaining with Papanicolaou staining has been made. Usefulness of these markers in the detection and diagnosis of premalignant and malignant cervical epithelial changes for mass screening has been discussed. Using crude AG-e, pure AG-e, HSV-2, and HSV-1 antisera in a number of blind studies, no significant differences were found in the reproducibility of results. Observations indicated that a minimum of 30 cells must be analyzed to make data amenable to statistical analysis. Exfoliated cells from 62, 75, 77, and 94% of patients respectively diagnosed as mild, moderate, and marked atypia, and cancer were studied with antisera against total HSV-2. Similar results were observed with antisera against pure AG-e. No patient reacted with anti-AG-e or anti-HSV-1 antiserum in the absence of reactivity to antisera against total HSV-2 antigens. Studies using anti-ICP 12 and -ICP 14 antigens established the wide and specific staining character of anti-HSV-2 antisera. Morphologic preservation of cells by Papanicolaou staining after the FA procedures was considered satisfactory for diagnostic purposes. Our studies indicated the potential usefulness of anti-HSV-2 and anti-AG-e antisera in mass cervical cancer screening programs and cytology automation.</description><subject>Antigens, Viral - analysis</subject><subject>Carcinoma, Squamous Cell - immunology</subject><subject>Cells, Cultured</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>Herpes Genitalis - immunology</subject><subject>Humans</subject><subject>Immune Sera</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Simplexvirus - immunology</subject><subject>Specimen Handling</subject><subject>Uterine Cervical Dysplasia - immunology</subject><subject>Uterine Cervical Neoplasms - immunology</subject><subject>Vaginal Smears</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEUhYMotVb_gcKsRBejeUxeG0GKWqHgRtchk7mR6HSmJjMF_72pLS5d3QP3nHs5H0LnBN8QTMQtxhqXinJ1pci1xljKUh-gKcGal0JxfYimf5ZjdJLSB8aYYUInaCKoZFSwKWILiGtImxDHVNhuCO_QZZGKlY2fEFPh-1g4iJvgbFs422V9io68bROc7ecMvT0-vM4X5fLl6Xl-vywd43IoKa2B1rzxSlHCa_CYKlspVQkBhIhKaK5JQ7wHpT2hotKWSYaVdFQ1jHM2Q5e7u-vYf42QBrMKyUHb2g76MRnJJBcsd5qhamd0sU8pgjfrGHKBb0Ow2bIyWxBmC8IoYn5ZGZ1jF_v7Y72C5i-0h5P3d7s95JKbANEkFyATaEIEN5imD_8_-AG6QHaF</recordid><startdate>198110</startdate><enddate>198110</enddate><creator>Gupta, Prabodh K.</creator><creator>Aurelian, Laure</creator><creator>Frost, John K.</creator><creator>Carpenter, Jean M.</creator><creator>Klacsmann, Karen T.</creator><creator>Rosenshein, Neil B.</creator><creator>Tyrer, Harry W.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198110</creationdate><title>Herpesvirus antigens as markers for cervical cancer</title><author>Gupta, Prabodh K. ; Aurelian, Laure ; Frost, John K. ; Carpenter, Jean M. ; Klacsmann, Karen T. ; Rosenshein, Neil B. ; Tyrer, Harry W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-22be2b5df88215bef028a488466e116469591d1ffe89f12649a373087c28d3553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Antigens, Viral - analysis</topic><topic>Carcinoma, Squamous Cell - immunology</topic><topic>Cells, Cultured</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>Herpes Genitalis - immunology</topic><topic>Humans</topic><topic>Immune Sera</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Simplexvirus - immunology</topic><topic>Specimen Handling</topic><topic>Uterine Cervical Dysplasia - immunology</topic><topic>Uterine Cervical Neoplasms - immunology</topic><topic>Vaginal Smears</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Prabodh K.</creatorcontrib><creatorcontrib>Aurelian, Laure</creatorcontrib><creatorcontrib>Frost, John K.</creatorcontrib><creatorcontrib>Carpenter, Jean M.</creatorcontrib><creatorcontrib>Klacsmann, Karen T.</creatorcontrib><creatorcontrib>Rosenshein, Neil B.</creatorcontrib><creatorcontrib>Tyrer, Harry W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Prabodh K.</au><au>Aurelian, Laure</au><au>Frost, John K.</au><au>Carpenter, Jean M.</au><au>Klacsmann, Karen T.</au><au>Rosenshein, Neil B.</au><au>Tyrer, Harry W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Herpesvirus antigens as markers for cervical cancer</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>1981-10</date><risdate>1981</risdate><volume>12</volume><issue>2</issue><spage>S232</spage><epage>S258</epage><pages>S232-S258</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><abstract>A total of 393 patients representing cervical atypias, cancers, and nonneoplastic disease have been studied. Cellular specimens have been stained with antisera raised against total herpes type 2 virus (HSV-2) and subfractions labeled crude AG-e, pure AG-e, ICP 12, and ICP 14. Reproducibility, statistical significance, false positive and false negative results, specificity, and sensitivity of the various antisera have been investigated. Correlation of immunocytostaining with Papanicolaou staining has been made. Usefulness of these markers in the detection and diagnosis of premalignant and malignant cervical epithelial changes for mass screening has been discussed. Using crude AG-e, pure AG-e, HSV-2, and HSV-1 antisera in a number of blind studies, no significant differences were found in the reproducibility of results. Observations indicated that a minimum of 30 cells must be analyzed to make data amenable to statistical analysis. Exfoliated cells from 62, 75, 77, and 94% of patients respectively diagnosed as mild, moderate, and marked atypia, and cancer were studied with antisera against total HSV-2. Similar results were observed with antisera against pure AG-e. No patient reacted with anti-AG-e or anti-HSV-1 antiserum in the absence of reactivity to antisera against total HSV-2 antigens. Studies using anti-ICP 12 and -ICP 14 antigens established the wide and specific staining character of anti-HSV-2 antisera. Morphologic preservation of cells by Papanicolaou staining after the FA procedures was considered satisfactory for diagnostic purposes. Our studies indicated the potential usefulness of anti-HSV-2 and anti-AG-e antisera in mass cervical cancer screening programs and cytology automation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>6273263</pmid><doi>10.1016/0090-8258(81)90077-9</doi></addata></record>
fulltext fulltext
identifier ISSN: 0090-8258
ispartof Gynecologic oncology, 1981-10, Vol.12 (2), p.S232-S258
issn 0090-8258
1095-6859
language eng
recordid cdi_proquest_miscellaneous_73756300
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antigens, Viral - analysis
Carcinoma, Squamous Cell - immunology
Cells, Cultured
Female
Fluorescent Antibody Technique
Herpes Genitalis - immunology
Humans
Immune Sera
Male
Mass Screening
Simplexvirus - immunology
Specimen Handling
Uterine Cervical Dysplasia - immunology
Uterine Cervical Neoplasms - immunology
Vaginal Smears
title Herpesvirus antigens as markers for cervical cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T18%3A22%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Herpesvirus%20antigens%20as%20markers%20for%20cervical%20cancer&rft.jtitle=Gynecologic%20oncology&rft.au=Gupta,%20Prabodh%20K.&rft.date=1981-10&rft.volume=12&rft.issue=2&rft.spage=S232&rft.epage=S258&rft.pages=S232-S258&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/0090-8258(81)90077-9&rft_dat=%3Cproquest_cross%3E73756300%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73756300&rft_id=info:pmid/6273263&rft_els_id=0090825881900779&rfr_iscdi=true